Fournier Pharma, also known as Groupe Fournier, engages in the research, development, production, and marketing of molecules. It offers Dualtis, an association of fenofibrate and metformin; and other associations of products. The company provides its products for lipid disorders and cardiovascular diseases; prevention and treatment of human diseases; and metabolic diseases. It has manufacturing facilities in Dijon, France and Cork, Ireland. The company operates in Europe, Canada, China, South East Asia, Algeria, Bulgaria, Thailand, and Turkey markets; and serves France, the United States, Italy, Canada, and European markets. Fournier Pharma was founded in 1880 and is based in Dijon, France. As of July 28, 2005, Fournier Pharma is a subsidiary of Solvay SA.